<DOC>
	<DOC>NCT02694146</DOC>
	<brief_summary>To evaluate the efficacy and safety of platelet rich plasma (PRP) in patients with coxarthrosis who donÂ´t respond to treatment with NSAIDs, compared to treatment with hyaluronic acid (Hylan G-F 20).</brief_summary>
	<brief_title>Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis, Hip</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<criteria>Patients&gt; 30 years. Patients who voluntarily express their intention to participate by informed consent. Diagnosis of coxarthrosis who have failed conservative treatments for 6 months Women of childbearing potential must have a negative pregnancy test during screening and must agree to use adequate contraception (or two contraceptive methods, of which one is barrier) while participating in the trial. Treatment with infiltrations 3 months prior to the study Prior treatment with NSAIDs 24h prior to extraction PreSurgical Treatment of Hip affects Diabetics Severe liver or kidney disease at the time of extraction Thrombocytopenia (&lt;100,000 platelets / ml) at baseline Anemia (Hb 9 &lt;mg / dl) at baseline Hyaluronic acid Allergy History crystal arthropathy, inflammatory arthritis or neuropathic arthropathy. Acetabular protrusions History of infectious arthritis Excessive deformity (acetabular dysplasia, Perthes)</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>platelet-rich plasma (PRP)</keyword>
	<keyword>hyaluronic acid (Hylan G-F 20).</keyword>
	<keyword>NSAIDs</keyword>
	<keyword>WOMAC</keyword>
</DOC>